{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:51:37Z","timestamp":1794671497794,"version":"4.9.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The aim of the study was to analyze the long-term outcome (&gt;20 years) after treatment of posterior fossa medulloblastoma (MB) in childhood. We analyzed data from patients treated for posterior fossa MB between 1974 (introduction of the first international treatment protocol in Norway) and 1987 (when use of radiotherapy was abandoned in children under 4 years of age). Out of 47 children, 24 survived &gt;20 years. At the time of analysis, 16 patients (median age 41 years, range 32\u201352) were alive (median follow-up 34 years, range 30\u201342), while 8 patients died 22\u201341 years (median 31 years) after primary treatment: one late death (after 22 years) was due to tumor recurrence whilst other 7 deaths (after 23 to 41 years) were related to the detrimental effects of the treatment (secondary tumors, stroke, severe epilepsy and depression). Observed 20- and 30-year survival rates were 51% and 44%, respectively. Despite successful treatment of MB in childhood and satisfactory tumor control during the first 20 years following primary treatment, our data indicates that even long-term survivors may die from tumor recurrence. However, the main factors causing late mortality and morbidity in long-term survivors seem to be the complications related to radiotherapy given in childhood.<\/jats:p>","DOI":"10.1038\/s41598-020-66328-8","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T06:03:15Z","timestamp":1591768995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-0542","authenticated-orcid":false,"given":"Radek","family":"Fri\u010d","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernt Johan","family":"Due-T\u00f8nnessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tryggve","family":"Lundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arild","family":"Egge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e5rd","family":"Kronen Krossnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Due-T\u00f8nnessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Stensvold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Brandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"key":"66328_CR1","doi-asserted-by":"crossref","unstructured":"Helseth, E., Due-Tonnessen, B., Wesenberg, F., Lote, K. & Lundar, T. Posterior fossa medulloblastoma in children and young adults (0\u201319 years): survival and performance. Childs Nerv Syst 15:451\u2013455; discussion 456 (1999)","DOI":"10.1007\/s003810050437"},{"key":"66328_CR2","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/neuonc\/not309","volume":"16","author":"E Desandes","year":"2014","unstructured":"Desandes, E., Guissou, S., Chastagner, P. & Lacour, B. Incidence and survival of children with central nervous system primitive tumors in the French National Registry of Childhood Solid Tumors. Neuro Oncol 16, 975\u2013983 (2014).","journal-title":"Neuro Oncol"},{"key":"66328_CR3","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.ejca.2009.01.015","volume":"45","author":"K von Hoff","year":"2009","unstructured":"von Hoff, K. et al. Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer 45, 1209\u20131217 (2009).","journal-title":"Eur J Cancer"},{"key":"66328_CR4","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s00381-014-2388-5","volume":"30","author":"T Gudrunardottir","year":"2014","unstructured":"Gudrunardottir, T. et al. Treatment developments and the unfolding of the quality of life discussion in childhood medulloblastoma: a review. Childs Nerv Syst 30, 979\u2013990 (2014).","journal-title":"Childs Nerv Syst"},{"key":"66328_CR5","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/neuonc\/nor015","volume":"13","author":"K Edelstein","year":"2011","unstructured":"Edelstein, K. et al. Early aging in adult survivors of childhood medulloblastoma: long-term neurocognitive, functional, and physical outcomes. Neuro Oncol 13, 536\u2013545 (2011).","journal-title":"Neuro Oncol"},{"key":"66328_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1055\/s-2005-872880","volume":"36","author":"K Ribi","year":"2005","unstructured":"Ribi, K. et al. Outcome of medulloblastoma in children: long-term complications and quality of life. Neuropediatrics 36, 357\u2013365 (2005).","journal-title":"Neuropediatrics"},{"key":"66328_CR7","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/neuonc\/not138","volume":"16","author":"PJ Piscione","year":"2014","unstructured":"Piscione, P. J., Bouffet, E., Mabbott, D. J., Shams, I. & Kulkarni, A. V. Physical functioning in pediatric survivors of childhood posterior fossa brain tumors. Neuro Oncol 16, 147\u2013155 (2014).","journal-title":"Neuro Oncol"},{"key":"66328_CR8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2214\/ajr.105.1.43","volume":"105","author":"HJ Bloom","year":"1969","unstructured":"Bloom, H. J., Wallace, E. N. & Henk, J. M. The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med 105, 43\u201362 (1969).","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"66328_CR9","first-page":"464","volume":"26","author":"DM Tait","year":"1990","unstructured":"Tait, D. M., Thornton-Jones, H., Bloom, H. J., Lemerle, J. & Morris-Jones, P. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 26, 464\u2013469 (1990).","journal-title":"Eur J Cancer"},{"key":"66328_CR10","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1200\/JCO.18.00969","volume":"37","author":"R Salloum","year":"2019","unstructured":"Salloum, R. et al. Late Morbidity and Mortality Among Medulloblastoma Survivors Diagnosed Across Three Decades: A Report From the Childhood Cancer Survivor Study. J Clin Oncol 37, 731\u2013740 (2019).","journal-title":"J Clin Oncol"},{"key":"66328_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S1470-2045(15)00167-9","volume":"17","author":"TI Yock","year":"2016","unstructured":"Yock, T. I. et al. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol 17, 287\u2013298 (2016).","journal-title":"Lancet Oncol"},{"key":"66328_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1080\/0284186X.2017.1301679","volume":"56","author":"E Stensvold","year":"2017","unstructured":"Stensvold, E. et al. Outcome for children treated for medulloblastoma and supratentorial primitive neuroectodermal tumor (CNS-PNET) - a retrospective analysis spanning 40 years of treatment. Acta Oncol 56, 698\u2013705 (2017).","journal-title":"Acta Oncol"},{"key":"66328_CR13","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/pbc.25599","volume":"62","author":"JE Frandsen","year":"2015","unstructured":"Frandsen, J. E., Wagner, A., Bollo, R. J., Shrieve, D. C. & Poppe, M. M. Long-term life expectancy for children with ependymoma and medulloblastoma. Pediatr Blood Cancer 62, 1986\u20131991 (2015).","journal-title":"Pediatr Blood Cancer"},{"key":"66328_CR14","first-page":"61","volume":"14","author":"FI Mahoney","year":"1965","unstructured":"Mahoney, F. I. & Barthel, D. W. Functional evaluation: the Barthel index. Md State Med J 14, 61\u201365 (1965).","journal-title":"Md State Med J"},{"key":"66328_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/neuonc\/nos267","volume":"15","author":"RJ Packer","year":"2013","unstructured":"Packer, R. J., Zhou, T., Holmes, E., Vezina, G. & Gajjar, A. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children\u2019s Oncology Group trial A9961. Neuro Oncol 15, 97\u2013103 (2013).","journal-title":"Neuro Oncol"},{"key":"66328_CR16","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s11060-009-9927-z","volume":"95","author":"P Frange","year":"2009","unstructured":"Frange, P. et al. From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980\u20132000). J Neurooncol 95, 271\u2013279 (2009).","journal-title":"J Neurooncol"},{"key":"66328_CR17","first-page":"988","volume":"76","author":"VP Collins","year":"1956","unstructured":"Collins, V. P., Loeffler, R. K. & Tivey, H. Observations on growth rates of human tumors. Am J Roentgenol Radium Ther Nucl Med 76, 988\u20131000 (1956).","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"66328_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0303-8467(97)80007-8","volume":"99","author":"U Sure","year":"1997","unstructured":"Sure, U., Berghorn, W. J. & Bertalanffy, H. Collins\u2019 law. Prediction of recurrence or cure in childhood medulloblastoma? Clin Neurol Neurosurg 99, 113\u2013116 (1997).","journal-title":"Clin Neurol Neurosurg"},{"key":"66328_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11060-014-1712-y","volume":"122","author":"MS Ning","year":"2015","unstructured":"Ning, M. S., Perkins, S. M., Dewees, T. & Shinohara, E. T. Evidence of high mortality in long term survivors of childhood medulloblastoma. J Neurooncol 122, 321\u2013327 (2015).","journal-title":"J Neurooncol"},{"key":"66328_CR20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s00381-010-1385-6","volume":"27","author":"M Vinchon","year":"2011","unstructured":"Vinchon, M., Baroncini, M., Leblond, P. & Delestret, I. Morbidity and tumor-related mortality among adult survivors of pediatric brain tumors: a review. Childs Nerv Syst 27, 697\u2013704 (2011).","journal-title":"Childs Nerv Syst"},{"key":"66328_CR21","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1200\/JCO.2003.01.202","volume":"21","author":"RJ Packer","year":"2003","unstructured":"Packer, R. J. et al. Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 21, 3255\u20133261 (2003).","journal-title":"J Clin Oncol"},{"key":"66328_CR22","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1470-2045(04)01507-4","volume":"5","author":"RK Mulhern","year":"2004","unstructured":"Mulhern, R. K., Merchant, T. E., Gajjar, A., Reddick, W. E. & Kun, L. E. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5, 399\u2013408 (2004).","journal-title":"Lancet Oncol"},{"key":"66328_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/0880010390158595","volume":"20","author":"M Macedoni-Luksic","year":"2003","unstructured":"Macedoni-Luksic, M., Jereb, B. & Todorovski, L. Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap. Pediatr Hematol Oncol 20, 89\u2013101 (2003).","journal-title":"Pediatr Hematol Oncol"},{"key":"66328_CR24","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1093\/neuonc\/nou321","volume":"17","author":"ME Gunn","year":"2015","unstructured":"Gunn, M. E. et al. Late morbidity in long-term survivors of childhood brain tumors: a nationwide registry-based study in Finland. Neuro Oncol 17, 747\u2013756 (2015).","journal-title":"Neuro Oncol"},{"key":"66328_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1023\/A:1018464328836","volume":"8","author":"AM Goldstein","year":"1997","unstructured":"Goldstein, A. M., Yuen, J. & Tucker, M. A. Second cancers after medulloblastoma: population-based results from the United States and Sweden. Cancer Causes Control 8, 865\u2013871 (1997).","journal-title":"Cancer Causes Control"},{"key":"66328_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/jnci\/djp104","volume":"101","author":"JH Olsen","year":"2009","unstructured":"Olsen, J. H. et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst 101, 806\u2013813 (2009).","journal-title":"J Natl Cancer Inst"},{"key":"66328_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/00043426-200110000-00008","volume":"23","author":"T Stavrou","year":"2001","unstructured":"Stavrou, T. et al. Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23, 431\u2013436 (2001).","journal-title":"J Pediatr Hematol Oncol"},{"key":"66328_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11060-004-3009-z","volume":"72","author":"AM Maddrey","year":"2005","unstructured":"Maddrey, A. M. et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 72, 245\u2013253 (2005).","journal-title":"J Neurooncol"},{"key":"66328_CR29","doi-asserted-by":"publisher","unstructured":"Stensvold, E. et al. Unmet rehabilitation needs in 86% of Norwegian paediatric embryonal brain tumour survivors. Acta Paediatrica, https:\/\/doi.org\/10.1111\/apa.15188 (2020)","DOI":"10.1111\/apa.15188"},{"key":"66328_CR30","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S1470-2045(13)70449-2","volume":"14","author":"V Ramaswamy","year":"2013","unstructured":"Ramaswamy, V. et al. Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. Lancet Oncol 14, 1200\u20131207 (2013).","journal-title":"Lancet Oncol"},{"key":"66328_CR31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-013-1197-0","volume":"115","author":"SM Perkins","year":"2013","unstructured":"Perkins, S. M., Fei, W., Mitra, N. & Shinohara, E. T. Late causes of death in children treated for CNS malignancies. J Neurooncol 115, 79\u201385 (2013).","journal-title":"J Neurooncol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66328-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66328-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:11:19Z","timestamp":1670310679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66328-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66328"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66328-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9371"}}